These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 375343)

  • 1. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of new alpha-glucosidase inhibitors (BAY m 1099 and BAY o 1248) on meal-stimulated increases in glucose and insulin levels in man.
    Hillebrand I; Boehme K; Graefe KH; Wehling K
    Klin Wochenschr; 1986 Apr; 64(8):393-6. PubMed ID: 3517475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of glucosidase inhibitor, Bay g 5421 (acarbose), on the blood glucose in obese diabetic patients ty pe 2 (NIDDM) (author's transl)].
    Laube H; Fouladfar M; Aubell R; Schmitz H
    Arzneimittelforschung; 1980; 30(7):1154-7. PubMed ID: 7191299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.
    Walton RJ; Sherif IT; Noy GA; Alberti KG
    Br Med J; 1979 Jan; 1(6158):220-1. PubMed ID: 369651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K; Turton J
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Thomas G; Puls W
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of two new alpha-glucosidase inhibitors on metabolic responses to a mixed meal in normal volunteers.
    Kennedy FP; Miles JM; Heiling V; Gerich JE
    Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):633-40. PubMed ID: 3326689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nutritive effects of an intestinal alpha-glucosidases-inhibition in rats (author's transl)].
    Kirchgessner M; Roth FX; Spoerl R
    Res Exp Med (Berl); 1981; 178(3):211-7. PubMed ID: 7015437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.
    Sachse G; Willms B
    Diabetologia; 1979 Nov; 17(5):287-90. PubMed ID: 387504
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor.
    Zavaroni I; Reaven GM
    Metabolism; 1981 Apr; 30(4):417-20. PubMed ID: 7010078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man.
    Scheen AJ; de Magalhaes AC; Salvatore T; Lefebvre PJ
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():50-4. PubMed ID: 7818725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozotocin-induced diabetic rats.
    Yamashita K; Sugawara S; Sakairi I
    Horm Metab Res; 1984 Apr; 16(4):179-82. PubMed ID: 6373545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the alpha-glucosidase inhibitor acarbose on postprandial serum glucose and insulin concentrations in healthy dogs.
    Robertson J; Nelson R; Kass P; Neal L
    Am J Vet Res; 1999 May; 60(5):541-5. PubMed ID: 10328421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Glucosidase inhibition in obesity.
    William-Olsson T
    Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.